Receives FTC Approval to Acquire Lannett Company - Aurobindo Pharma Ltd

Code BSE: 524804 NSE: $AUROPHARMA Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company Lannett, a Pennsylvania-based generic pharmaceutical company, specializes in the development and commercialization of a diversified portfolio of complex, non-opioid controlled substances. The acquisition will significantly expand Aurobindo USA’s product offering in this segment while adding a U.S.-based manufacturing facility to its network.